Modern Nuclear, INC.
Modern Nuclear, INC. was paid $1.60M by Medicaid between Mar 2018 and Dec 2024, across 10 billing codes. Its largest line is 78431, — 52% of everything it billed.
33Billing provider infoMODERN NUCLEAR, INC.
LA HABRA, CA 90631
LA HABRA, CA 90631
33aNPI1063851335assigned 06/20/2013
33bProvider typeNuclear Medicine Technology Radiologic Technologist
28Total paid$1.60M
24GClaims12,855
24DCodes billed10
24AFirst – last monthMar 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48 | $11K | |
| 2019 | 382 | $167K | |
| 2020 | 297 | $114K | |
| 2021 | 1,029 | $201K | |
| 2022 | 2,628 | $343K | |
| 2023 | 4,697 | $512K | |
| 2024incomplete | 3,774 | $255K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78431 | 52% | 1,814 | 1,814 | $835K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 37% | 2,351 | 2,349 | $599K |
| 78434 | 3.4% | 1,996 | 1,996 | $54K | |
| G0235 | Pet imaging, any site, not otherwise specified | 3.2% | 252 | 250 | $51K |
| 93015 | 2.0% | 1,550 | 1,550 | $31K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 2,412 | 2,411 | $25K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 624 | 624 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 770 | 770 | $101.27 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,059 | 1,058 | $1.03 |
| 78492 | 0% | 27 | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAVERTY, PATRICK (CEO)